RT Journal Article
SR Electronic
T1 Development and validation of nomogram to predict long-term prognosis of critically ill patients with acute myocardial infarction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.14.20174953
DO 10.1101/2020.08.14.20174953
A1 Yiyang Tang
A1 Lihuang Zha
A1 Xiaofang Zeng
A1 Yilu Feng
A1 Wenchao Lin
A1 Zhenghui Liu
A1 Zaixin Yu
YR 2020
UL http://medrxiv.org/content/early/2020/08/16/2020.08.14.20174953.abstract
AB Background Acute myocardial infarction (AMI) is a common critical illness in the cardiovascular field, with poor prognosis. This study aimed to construct a nomogram to predict long-term survival of critically ill patients with AMI, which helps to assess severity, guide treatment, and improve prognosis.Methods and results The clinical data of patients with AMI was extracted from the database MIMIC-III v1.4. The Cox proportional hazards models were performed to identify the independently prognostic factors, and a nomogram for predicting long-term survival of AMI patients was developed based on the multifactor analysis, of which discriminative ability and accuracy was evaluated by concordance index (C-index) and calibration curve.Results A total of 1202 patients were included in the analysis, of which 841 were divided into the training set and 361 were the validation. Multivariate analysis shown that age, blood urea nitrogen, respiratory rate, SAPSII score, cardiogenic shock, cardiac arrhythmias, and respiratory failure served as the independently predictive factors, which were incorporated into the nomogram. Moreover, the nomogram shown favorable performance for predicting 4-year survival of AMI patients with the C-index of 0.788 [95% confidence interval (CI): 0.763 to 0.813] and 0.783 (95% CI: 0.748 to 0.818) in the training and validation set, respectively.Conclusion The nomogram we constructed here can accurately predict the long-term survival of patients with AMI.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is a retrospective study, and trial ID is not required.Funding StatementOur study was supported by the National Natural Science Foundation of China (81873416) and the National Science and Technology Major Project (2017ZX0930401405).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Since this project has been approved by the institutional review boards of Massachusetts Institute of Technology (Cambridge, MA, USA) and Beth Israel Deaconess Medical Center (Boston, MA, USA) and the identifying elements related to patient privacy have been removed from the database, our research does not need to provide the additional approval of ethics committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPublicly available datasets were analyzed in this study. This data can be extracted from Monitoring in Intensive Care Database III version 1.4 (MIMIC-III v.1.4) after passing on the required courses and obtaining the authorization. https://mimic.physionet.org/